tm logo
ROECAD
Live/Registered
REGISTERED

on 01 Jan 2019

Last Applicant/ Owned by

3-5-1, Nihonbashi Honcho, Chuo-ku

Tokyo 103-8426

JP

Serial Number

87675546 filed on 07th Nov 2017

Registration Number

5640580 registered on 01st Jan 2019

in the Principal Register

Correspondent Address

Bassam N. Ibrahim

BASSAM N. IBRAHIM

1737 KING STREET, SUITE 500

ALEXANDRIA, VA 22314

Filing Basis

No Filing Basis

Disclaimer

NO DATA

ROECAD

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney di Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease

Mark Details


Serial Number

No 87675546

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 0076404-160

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
01st Jan 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01st Jan 2019REGISTERED-PRINCIPAL REGISTER
16th Oct 2018PUBLISHED FOR OPPOSITION
16th Oct 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26th Sep 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08th Sep 2018APPROVED FOR PUB - PRINCIPAL REGISTER
23rd Aug 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
23rd Aug 2018TEAS/EMAIL CORRESPONDENCE ENTERED
21st Aug 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
24th Feb 2018PRIORITY ACTION WRITTEN